Cambridge Cancer Genomics offers a better way to gauge effective cancer treatments

John Cassidy’s family has been at the forefront of cancer research for three generations now. The Cambridge-educated co-founder and Chief Executive Officer of cancer diagnostics company Cambridge Cancer Genomics was just following in his father’s and grandfather’s footsteps when he took up researching the disease in college. Cassidy’s father was head of cancer therapies…